| Product Code: ETC10326732 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Spinal Muscular Atrophy Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Spinal Muscular Atrophy Market - Industry Life Cycle |
3.4 Netherlands Spinal Muscular Atrophy Market - Porter's Five Forces |
3.5 Netherlands Spinal Muscular Atrophy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Spinal Muscular Atrophy Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Netherlands Spinal Muscular Atrophy Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.8 Netherlands Spinal Muscular Atrophy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Netherlands Spinal Muscular Atrophy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals and patients about spinal muscular atrophy (SMA) in the Netherlands. |
4.2.2 Advances in SMA treatment options and therapies, leading to better patient outcomes. |
4.2.3 Supportive government initiatives and policies aimed at improving access to SMA treatments and healthcare services. |
4.3 Market Restraints |
4.3.1 High cost of SMA treatments and therapies, limiting affordability for some patients and healthcare systems. |
4.3.2 Limited availability of specialized healthcare facilities and experts for SMA management in the Netherlands. |
4.3.3 Challenges in early diagnosis and timely intervention for SMA patients, impacting treatment effectiveness. |
5 Netherlands Spinal Muscular Atrophy Market Trends |
6 Netherlands Spinal Muscular Atrophy Market, By Types |
6.1 Netherlands Spinal Muscular Atrophy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Type 1 (Infantile), 2021 - 2031F |
6.1.4 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Type 2 (Intermediate), 2021 - 2031F |
6.1.5 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Type 3 (Juvenile), 2021 - 2031F |
6.1.6 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Type 4 (Adult Onset), 2021 - 2031F |
6.1.7 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Netherlands Spinal Muscular Atrophy Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.2.3 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Drug Therapy, 2021 - 2031F |
6.2.4 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Nusinersen, 2021 - 2031F |
6.2.5 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Risdiplam, 2021 - 2031F |
6.2.6 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Supportive Care, 2021 - 2031F |
6.3 Netherlands Spinal Muscular Atrophy Market, By Therapy |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.3.3 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Occupational Therapy, 2021 - 2031F |
6.3.4 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Respiratory Therapy, 2021 - 2031F |
6.3.5 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Orthopedic Care, 2021 - 2031F |
6.3.6 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Assistive Devices, 2021 - 2031F |
6.4 Netherlands Spinal Muscular Atrophy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F |
6.4.4 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Netherlands Spinal Muscular Atrophy Market Revenues & Volume, By Others, 2021 - 2031F |
7 Netherlands Spinal Muscular Atrophy Market Import-Export Trade Statistics |
7.1 Netherlands Spinal Muscular Atrophy Market Export to Major Countries |
7.2 Netherlands Spinal Muscular Atrophy Market Imports from Major Countries |
8 Netherlands Spinal Muscular Atrophy Market Key Performance Indicators |
8.1 Patient survival rate post-treatment initiation. |
8.2 Average age of SMA diagnosis in the Netherlands. |
8.3 Number of healthcare facilities offering specialized SMA care services. |
8.4 Percentage of SMA patients receiving approved treatments within a specified timeframe. |
8.5 Patient-reported quality of life improvements following SMA treatment. |
9 Netherlands Spinal Muscular Atrophy Market - Opportunity Assessment |
9.1 Netherlands Spinal Muscular Atrophy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Spinal Muscular Atrophy Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Netherlands Spinal Muscular Atrophy Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.4 Netherlands Spinal Muscular Atrophy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Netherlands Spinal Muscular Atrophy Market - Competitive Landscape |
10.1 Netherlands Spinal Muscular Atrophy Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Spinal Muscular Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here